Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/1998
03/26/1998CA2266577A1 Immunological composition for detection of bladder cancer and method of using same
03/26/1998CA2266425A1 Human b-cell translocation genes-2 and 3
03/26/1998CA2266341A1 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
03/26/1998CA2266339A1 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
03/26/1998CA2264542A1 Human gtp binding protein gamma-3
03/26/1998CA2263821A1 Novel human interferon-inducible protein
03/26/1998CA2263818A1 Novel tumor proteins
03/26/1998CA2237191A1 Diagnostics for and mediators of inflammatory disorders
03/25/1998EP0831148A1 Human adhesion molecule occludin
03/25/1998EP0830601A1 Use of a phycobiliprotein-binding peptide complex as a fluorescent tracer
03/25/1998EP0830456A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE
03/25/1998EP0830450A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
03/25/1998EP0830448A1 Continuous selective clonogenic expansion of relatively undifferentiated cells
03/25/1998EP0830374A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
03/25/1998EP0830373A1 Cd6 ligand
03/25/1998EP0830370A1 N-1-carboxyalkyl derivatives of lsd
03/25/1998EP0830143A1 Use of leukemia inhibitory factor and endothelin antagonists
03/25/1998EP0830142A1 Viral agent associated with mystery swine disease
03/25/1998EP0830130A1 Tnf-alpha converting enzyme
03/25/1998EP0679094B1 Compounds for targeting
03/25/1998CN1177302A Lymphotoxin-
03/25/1998CN1037844C Tnf-muteins
03/24/1998US5731428 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
03/24/1998US5731427 Nucleic acids encoding a gap-associated protein
03/24/1998US5731200 Isolated nucleic acid encoding receptor-like TGF-β1 binding protein
03/24/1998US5731195 Specified amino acid sequences
03/24/1998US5731189 Human monoclonal antibodies to human immunodeficiency virus
03/24/1998US5731170 DNA encoding a growth factor specific for epithelial cells
03/24/1998US5731169 cDNA fragment coding the alpha interferon receptor gene and process for the preparation of a corresponding protein
03/24/1998US5731168 Method for making heteromultimeric polypeptides
03/24/1998US5731166 Recombinant production of chemotactic CP-10 polypeptides and therapeutic methods using them
03/24/1998US5731154 Method for detecting human contactin
03/24/1998US5731151 Tuberculosis vaccine
03/24/1998US5731149 Antibiotic cryptdin peptides and methods of their use
03/24/1998US5730990 Non-antigenic amine derived polymers and polymer conjugates
03/24/1998US5730985 Methyl ecgonine phenylphosphonate as chemical intermediate of cocaine
03/24/1998US5730983 Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
03/24/1998US5730982 Therapeutic use of hypervariable region of monoclonal antibody M195 and constructs thereof
03/24/1998US5730981 Monoclonal anti-ganglioside antibody and its preparation
03/24/1998US5730980 Methods and compositions for ameliorating the symptoms of sepsis
03/24/1998US5730979 LO-CD2a antibody and uses thereof for inhibiting T cell activation and proliferation
03/24/1998US5730978 Inhibition of lymphocyte adherence with α4β1-specific antibodies
03/24/1998US5730977 Anti-VEGF human monoclonal antibody
03/24/1998US5730976 Method for treating macrophage pathogen infections by TGF-B antagonists
03/24/1998US5730975 Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function
03/24/1998US5730970 Pharmaceutical compositions comprising human interleukin-4 (IL-4)
03/24/1998CA1339776C Equine-gamma-interferon
03/24/1998CA1339775C Antibody 0.5b to hiv-i gp 120 modified with toxic substance
03/19/1998WO1998011435A1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity
03/19/1998WO1998011241A1 Oligocistronic expression system for the production of heteromeric proteins
03/19/1998WO1998011236A1 Aspartic protease
03/19/1998WO1998011229A2 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
03/19/1998WO1998011227A1 Granulocyte chemotactic protein 2 variant
03/19/1998WO1998011225A2 A novel haemopoietin receptor and genetic sequences encoding same
03/19/1998WO1998011223A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
03/19/1998WO1998011218A1 Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use
03/19/1998WO1998011214A1 Mammalian and human rec2
03/19/1998WO1998011212A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998WO1998011204A1 Methods and reagents for regulating telomere length and telomerase activity
03/19/1998WO1998011139A1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
03/19/1998WO1998011133A1 New picornaviruses, vaccines and diagnostic kits
03/19/1998WO1998011117A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism
03/19/1998WO1998011116A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity
03/19/1998WO1998010795A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same
03/19/1998WO1998010792A1 Immune direction therapy
03/19/1998WO1998010791A1 Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes
03/19/1998WO1998010788A1 Staphylococcus aureus antigen
03/19/1998WO1998010787A2 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998WO1998010777A1 Nucleosome-based anti-tumor compositions
03/19/1998WO1998010776A1 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
03/19/1998WO1998010652A1 NOVEL trpS
03/19/1998CA2265927A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
03/19/1998CA2265913A1 Methods and reagents for regulating telomere length and telomerase activity
03/19/1998CA2265887A1 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
03/19/1998CA2265885A1 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998CA2265670A1 Nucleosome-based anti-tumor compositions
03/19/1998CA2265631A1 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
03/19/1998CA2265492A1 Mammalian and human rec2
03/19/1998CA2265467A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998CA2265455A1 Granulocyte chemotactic protein 2 variant
03/19/1998CA2264938A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity
03/19/1998CA2264829A1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity
03/19/1998CA2264825A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism
03/19/1998CA2264541A1 Human protein kinases
03/18/1998EP0829265A1 Method for priming a circuit for multiple blood extracorporeal treatments
03/18/1998EP0828831A2 A novel human purinergic p 2u? receptor
03/18/1998EP0828830A1 Eb1 gene product binds to apc
03/18/1998EP0828828A2 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2
03/18/1998EP0828756A2 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
03/18/1998EP0828751A1 Human neuropeptide receptor
03/18/1998EP0828517A1 Conjugates of folate and anti-effector cell antibodies
03/18/1998EP0828512A1 Murine and human box-dependent myc-interacting protein (bin1) and uses therefor
03/18/1998EP0739214B1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
03/18/1998EP0525119B1 Antibody conjugates for treatment of neoplastic disease
03/18/1998CN1176659A A method for making heteromultimeric polypeptides
03/18/1998CN1176658A Vaccine and antitoxin for treatment and prevention of C. difficile disease
03/18/1998CN1176603A Vascular endothelial growth factor-B
03/18/1998CN1176391A Monoclonal antibodies against human interleukin-4 and hybridowas producing the same
03/18/1998CN1176307A Preparation of selenic antibody enzyme with activity higher than that of natural enzyme
03/17/1998US5728821 Mutant BR96 antibodies reactive with human carcinomas
1 ... 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 ... 1494